Colleagues, the next big thing that we have to figure out is how we want to schedule the concurrent studies that we have now adopted. These are the study that Madam Dancho put forward last week that we adopted and the study that Mr. Bardeesy put forward.
What I'm going to do is suspend very briefly, and here's why: I would like the representatives from each party to speak over here with the clerk and the analysts, so that we're all on the same page in terms of finding out what's going to be the most effective and efficient way of scheduling this. We can see if we can come to a very quick agreement, which I imagine we will, and then we will come back publicly here and have a general consensus, I hope, about what that schedule looks like.
To summarize, I'm going to suspend. We're going to talk to the analysts, the clerk and the reps from each party to determine what the schedule of this concurrent study is going to look like.
The last thing I will say is that, now that we have substantial orders of business in front of us and a path forward, please make sure as soon as possible that you're starting to get your witness lists with contact information in to the clerk and the analysts. It's very difficult. What often happens is that we have a meeting on a Wednesday, and we have five people whose names are there, but four of them aren't available. We want to make sure we have a really solid, critical mass of people ready to go, so that we have that manoeuvrability when necessary.
I'm going to very quickly suspend. We'll try to get some agreement on a schedule for these two studies, and we will report back very soon.
Thank you.